Older patients prescribed donepezil had a higher risk for hospital admission for rhabdomyolysis than patients prescribed rivastigmine or galantamine, according to a population-based cohort study ...
Credit: Getty Images. A PDUFA target date of June 30, 2020 has been assigned to the application. The Food and Drug Administration has accepted for filing the New Drug Application (NDA) for Adlarity ...
Credit: Shutterstock. Adlarity is a once-weekly transdermal formulation of donepezil that is designed to be worn for 7 days with consistent adhesion. The Food and Drug Administration (FDA) has ...
Salzburg, Austria - Treatment with ARICEPT® (donepezil hydrochloride tablets) significantly improved the cognitive and global (overall) function of patients with vascular dementia (VaD), compared with ...
Alzheimer's disease is the world's most common neurodegenerative disease, affecting more than 50 million people globally. Alzheimer's disease is also among the most fatal, landing as one of the top ...
Oral medications may be covered by a stand-alone Medicare Part D plan or a Medicare Advantage Prescription Drug (MAPD) plan. Both types of plans are approved by Medicare but administered by private ...
SEOUL, South Korea--(BUSINESS WIRE)--Icure Pharmaceutical Inc. (KOSDAQ: 175250), a biopharmaceutical company in Korea, announced today that its donepezil patch, a treatment of Alzheimer’s-type ...
Results of a recent neuroanatomical study of patients with dementia of the Alzheimer type (DAT) indicate that certain variations in hippocampal structure and volume correlate with a poorer response to ...
Aricept, blarcamesine, simufilam, and panax ginseng by acting as acetylcholinesterase inhibitors and as indirect antioxidants, positively affecting cognition during the early stages of Alzheimer's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback